Prevalence and correlates of fatigue in chronic kidney disease and end-stage renal disease: Are sleep disorders a key to understanding fatigue?

American Journal of Nephrology

Volumn 38, Issue 6, 2014, Pages 489-495

  Jhamb, Manisha ^a   Liang, Kelly ^a   Yabes, Jonathan ^b   Steel, Jennifer L ^a,b   Dew, Mary Amanda ^b   Shah, Nirav ^a   Unruh, Mark ^c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic kidney disease; End stage renal disease; FACIT F scale; Fatigue; Sleep

Indexed keywords

ALBUMIN; BENZODIAZEPINE; HEMOGLOBIN;

ADULT; ALBUMIN BLOOD LEVEL; APNEA HYPOPNEA INDEX; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL ASSESSMENT TOOL; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DAYTIME SOMNOLENCE; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; END STAGE RENAL DISEASE; FATIGUE; FEMALE; FUNCTIONAL ASSESSMENT OF CHRONIC ILLNESS THERAPY FATIGUE; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; PRIORITY JOURNAL; QUESTIONNAIRE; RESTLESS LEGS SYNDROME; SHORT FORM 36; SLEEP; SLEEP DISORDER; SLEEP DISORDERED BREATHING; SLEEP QUALITY; ASSESSMENT OF HUMANS; HEMOGLOBIN BLOOD LEVEL; HYPOXEMIA; PATIENT HEALTH QUESTIONNAIRE 9; REM SLEEP;

ADULT; AGED; ALBUMINS; BENZODIAZEPINES; CARDIOVASCULAR DISEASES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DEPRESSION; FATIGUE; FEMALE; GLOMERULAR FILTRATION RATE; HEMOGLOBINS; HUMANS; KIDNEY FAILURE, CHRONIC; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYSOMNOGRAPHY; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRES; RENAL INSUFFICIENCY, CHRONIC; RESTLESS LEGS SYNDROME; SLEEP DISORDERS;

EID: 84893132979     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000356939     Document Type: Article

References (34)

1. Jhamb M, et al: Design and rationale of health-related quality of life and patient-reported outcomes assessment in the Frequent Hemodialysis Network trials. Blood Purif 2011; 31: 151-158.
2. Kliger AS, Fishbane S, Finkelstein FO: Eryth-ropoietic stimulating agents and quality of a patient's life: individualizing anemia treatment. Clin J Am Soc Nephrol 2012; 7: 354-357.
3. Murtagh FE, et al: Symptoms in advanced renal disease: a cross-sectional survey of symptom prevalence in stage 5 chronic kidney disease managed without dialysis. J Palliat Med 2007; 10: 1266-1276. (Pubitemid 350308628)
4. Murtagh FE, Addington-Hall J, Higginson IJ: The prevalence of symptoms in end-stage renal disease: a systematic review. Adv Chronic Kidney Dis 2007; 14: 82-99. (Pubitemid 46014531)
5. Bonner A, Wellard S, Caltabiano M: The impact of fatigue on daily activity in people with chronic kidney disease. J Clin Nurs 2010; 19: 3006-3015.
6. Fukuhara S, et al: Understanding measurements of vitality in patients with chronic kidney disease: connecting a quality-of-life scale to daily activities. PLoS One 2012; 7:e40455.
7. Macdonald JH, et al: Exertional fatigue in patients with CKD. Am J Kidney Dis 2012; 60: 930-939.
8. Roumelioti ME, et al: Sleep-disordered breathing and excessive daytime sleepiness in chronic kidney disease and hemodialysis. Clin J Am Soc Nephrol 2011; 6: 986-994.
9. Jhamb M, et al: Correlates and outcomes of fatigue among incident dialysis patients. Clin J Am Soc Nephrol 2009; 4: 1779-1786.
10. Unruh ML, et al: Sleep quality and its correlates in the first year of dialysis. Clin J Am Soc Nephrol 2006; 1: 802-810.
11. Yngman-Uhlin P, Edell-Gustafsson U: Self-reported subjective sleep quality and fatigue in patients with peritoneal dialysis treatment at home. Int J Nurs Pract 2006; 12: 143-152.
12. 2a, and filgrastim or doxorubicin/docetaxel in patients with advanced gastric cancer with quality-of-life assessment: Eastern Cooperative Oncology Group Study E6296. Cancer J 2002; 8: 282-286.
13. Yellen SB, et al: Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage 1997; 13: 63-74. (Pubitemid 27147321)
14. Cella D, et al: Fatigue in cancer patients compared with fatigue in the general United States population. Cancer 2002; 94: 528-538. (Pubitemid 34081385)
15. DeOreo PB: Hemodialysis patient-assessed functional health status predicts continued survival, hospitalization, and dialysis-attendance compliance. Am J Kidney Dis 1997; 30: 204-212.
16. Buysse DJ, et al: The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989; 28: 193-213. (Pubitemid 19144991)
17. Johns MW: A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 1991; 14: 540-545.
18. Allen RP, Earley CJ: Validation of the Johns Hopkins restless legs severity scale. Sleep Med 2001; 2: 239-242. (Pubitemid 34846773)
19. Kroenke K, Spitzer RL, Williams JB: The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001; 16: 606-613. (Pubitemid 32823891)
20. Rechtschaffen A, Kales A: A Manual of Standardized Terminology, Techniques, and Scoring System for Sleep Stages of Human Subjects. Bethesda, US Department of Health, Education, and Welfare Public Health Service-NIH/NIND. 1968.
21. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999; 22: 667-689.
22. Caplin B, Kumar S, Davenport A: Patients' perspective of haemodialysis-associated symptoms. Nephrol Dial Transplant 2011; 26: 2656-2663.
23. Bossola M, Luciani G, Tazza L: Fatigue and its correlates in chronic hemodialysis patients. Blood Purif 2009; 28: 245-252.
24. Karakan S, Sezer S, Ozdemir FN: Factors related to fatigue and subgroups of fatigue in patients with end-stage renal disease. Clin Nephrol 2011; 76: 358-364.
25. Jhamb M, et al: Impact of fatigue on outcomes in the hemodialysis (HEMO) study. Am J Nephrol 2011; 33: 515-523.
26. Herselman M, et al: Relationship between serum protein and mortality in adults on long-term hemodialysis: exhaustive review and meta-analysis. Nutrition 2010; 26: 10-32.
27. Rambod M, et al: Association of Malnutrition-Inflammation Score with quality of life and mortality in hemodialysis patients: a 5-year prospective cohort study. Am J Kidney Dis 2009; 53: 298-309.
28. Kalantar-Zadeh K, et al: A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis 2001; 38: 1251-1263. (Pubitemid 34193111)
29. Kalantar-Zadeh K, et al: Comparing outcome predictability of markers of malnutrition-inflammation complex syndrome in haemodi-alysis patients. Nephrol Dial Transplant 2004; 19: 1507-1519. (Pubitemid 38796421)
30. Ikizler TA, et al: Prevention and treatment of protein energy wasting in chronic kidney disease patients: a consensus statement by the International Society of Renal Nutrition and Metabolism. Kidney Int 2013 (E-pub ahead of print).
31. Kopple JD, et al: OPPORTUNITY: a randomized clinical trial of growth hormone on outcome in hemodialysis patients. Clin J Am Soc Nephrol 2008; 3: 1741-1751.
32. Jhamb M, et al: Fatigue in patients receiving maintenance dialysis: a review of definitions, measures, and contributing factors. Am J Kidney Dis 2008; 52: 353-365. (Pubitemid 351978146)
33. Flemons WW, et al: Home diagnosis of sleep apnea: a systematic review of the literature. An evidence review cosponsored by the American Academy of Sleep Medicine, the American College of Chest Physicians, and the American Thoracic Society. Chest 2003; 124: 1543-1579. (Pubitemid 37290070)
34. Hacker ED, Ferrans CE: Ecological momentary assessment of fatigue in patients receiving intensive cancer therapy. J Pain Symptom Manage 2007; 33: 267-275. (Pubitemid 46349538)